Aker BioMarine

Oksenøyvn. 10 (Bygg B)

1366 Lysaker



Tel. +47 24 13 00 10


Nutraceutical and Functional Food Ingredients

Aker BioMarine

Aker BioMarine is an integrated biotechnology company – uniquely positioned to create value krill derived biotech products. The company is supplying biomarine ingredients through an optimized value chain from raw materials to customer.

Aker BioMarine utilizes its unique krill harvesting to develop its own downstream operations within the high value added nutraceutical and aquaculture feed markets.

Krill derived products, such as oil and meal, have a high content of bioactive ingredients, e.g. Omega-3 bound phospholipids and astaxanthin, which have documented positive effects on both humans and animals.

Aker BioMarine has registered Superba as the company`s brand name for nutraceutical and Qrill as the company’s brand name for its krill meal and krill oil products for aquaculture. Qrill has proven benefits to competing products in the aquaculture market. 

Following the merger with Natural in June 2007, Aker BioMarine has a wide set of capabilities within nutraceuticals (dietary supplements and functional foods) and is an experienced player in nutraceutical applications of lipids, product development, and intellectual property rights (IPR), R&D and product commercialization.

Products / Markets supplier image Click to Enlarge

Nutrition & Health Aker BioMarine has registered Superba as the company`s brandnames for its krill oil products for the human market. The Omega-3 phospholipids and astaxanthin found in krill promote among others physical and mental health.

Aker BioMarine has registered Qrill as the company’s brand name for its krill meal and krill oil products for aquaculture feed markets. Business activities have already succeeded in establishing a broad customer base in the market for Qrill meal deliveries to the aquaculture industry.

supplier banner image

Articles On NutritionInsight


Nutrition & Health News   18 October 2018

Krill harvesting: Aker BioMarine to build new support vessel in China

18 Oct 2018 --- Aker BioMarine is set to build its newest support vessel in China. After signing a memorandum of understanding with representatives from the China Overseas Development Association (CODA), Matts Johansen, CEO of Aker BioMarine noted: “This is the beginning of a unique collaboration bringing together innovative technologies and high-tech competencies from both Norwegian and Chinese companies.”

Nutrition & Health News   30 August 2018

Aker BioMarine partnership seeks to battle lupus with krill oil

30 Aug 2018 --- Aker BioMarine and Lupus Research Alliance have partnered to launch a new clinical study investigating how phospholipid-rich krill oil can benefit people with lupus, with the aim to lessen the severity of symptoms associated with the disease. The trial will include 76 people diagnosed with lupus from 20 different research centers, and each participant will each be given daily doses of phospholipid-rich krill oil over 12 months. The results are to be expected in 2020.

Nutrition & Health News   24 August 2018

Weekly Roundup: Two Aker Biomarine krill patents deemed unpatentable in US court, no single diet can eliminate belly fat

24 Aug 2018 --- The weekly roundup is NutritionInsight's collection of global nutrition stories from the past week. No single diet can specifically eliminate belly fat research has found, but certain healthful traits can reduce or prevent abdominal obesity. Sabinsa has added two new US staff members and NP Nutra has expanded its warehouse space in California. The European Commission has authorized microalgae oil, Schizochytrium, for novel food status and the US patent authorities have found that patents related to krill and its production held by Aker Biomarine are unpatentable, following petitions from Rimfrost AS. While, DSM has made Fortune Magazine’s 2018 Change the World list for the third consecutive year.

More Articles

Articles on The World of Food Ingredients


From TWOFI  01 August 2016

View From The Top: Matts Johansen, CEO, Aker BioMarine

01 Aug 2016 --- Aker BioMarine, the leading supplier of krill-derived products, ramped up its investment in R&D in 2015. Of the company’s turnover of $US105 million, $US20 million was reinvested into enabling technologies and the scientific support behind them.

From TWOFI  05 August 2015

Opinion Edge – The Right Personal Nutrition Approach

05 Aug 2015 --- Key suppliers offer their thoughts on the trends that will drive the nutritionals market forward. What is the future for personalized nutrition and which condition specific nutrition areas are on-trend?

Video Interviews


18 May 2017

Market Opportunities in Krill Oil

18 May 2017 --- Aker BioMarine recently reported how the company managed to grow sales and improve operations in the still-challenging omega-3 market, and continues to heavily invest in new technology and the development of new krill-derived products. Matts Johansen, CEO of Aker BioMarine, is satisfied with the result, but admitted that 2016 was still a challenging year for the company. Johansen said. “Although 2016 was a good year for Aker BioMarine, we posted slightly negative earnings after tax. The investments needed to build a supply chain for krill-based products, the resources needed to innovate and document their biological effects, and the time needed to develop new markets are reflected in our earnings.”